Search by Drug Name or NDC
NDC 42023-0239-01 METHYLPREDNISOLONE ACETATE 40 mg/mL Details
METHYLPREDNISOLONE ACETATE 40 mg/mL
METHYLPREDNISOLONE ACETATE is a INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is METHYLPREDNISOLONE ACETATE.
MedlinePlus Drug Summary
Methylprednisolone injection is used to treat severe allergic reactions. Methylprednisolone injection is used in the management of multiple sclerosis (a disease in which the nerves do not function properly), lupus (a disease in which the body attacks many of its own organs), gastrointestinal disease, and certain types of arthritis. Methylprednisolone injection is also used to treat certain conditions that affect the blood, skin, eyes, nervous system, thyroid, kidneys, and lungs. It is sometimes used in combination with other medications to treat symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Methylprednisolone injection is in a class of medications called corticosteroids. It works to treat people with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It also works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.
Related Packages: 42023-0239-01Last Updated: 04/07/2024
MedLinePlus Full Drug Details: Methylprednisolone Injection
Product Information
| NDC | 42023-0239 |
|---|---|
| Product ID | 42023-239_d5577a8b-6d4c-45d2-9eec-1c9df9a461f0 |
| Associated GPIs | |
| GCN Sequence Number | 006724 |
| GCN Sequence Number Description | methylprednisolone acetate VIAL 40 MG/ML INJECTION |
| HIC3 | P5A |
| HIC3 Description | GLUCOCORTICOIDS |
| GCN | 27003 |
| HICL Sequence Number | 002875 |
| HICL Sequence Number Description | METHYLPREDNISOLONE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | METHYLPREDNISOLONE ACETATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | METHYLPREDNISOLONE ACETATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mg/mL |
| Substance Name | METHYLPREDNISOLONE ACETATE |
| Labeler Name | Par Pharmaceutical, Inc. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214297 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42023-0239-01 (42023023901)
| NDC Package Code | 42023-239-01 |
|---|---|
| Billing NDC | 42023023901 |
| Package | 1 VIAL in 1 CARTON (42023-239-01) / 10 mL in 1 VIAL |
| Marketing Start Date | 2023-05-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |